TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p

M. Jasek; L. P. Gondek; N. Bejanyan; R. Tiu; J. Huh; K. S. Theil; C. O'Keefe; M. A. McDevitt; J. P. MacIejewski

doi:10.1038/leu.2009.189

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p

M. Jasek, L. P. Gondek, N. Bejanyan, R. Tiu, J. Huh, K. S. Theil, C. O'Keefe, M. A. McDevitt, J. P. MacIejewski

Department of Laboratory Medicine

Research output: Contribution to journal › Letter › peer-review

63 Scopus citations

Original language	English
Pages (from-to)	216-219
Number of pages	4
Journal	Leukemia
Volume	24
Issue number	1
DOIs	https://doi.org/10.1038/leu.2009.189
State	Published - Jan 2010

Access to Document

10.1038/leu.2009.189

Cite this

@article{019d089120bc4e30af0f3bbec2d6cd25,

title = "TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p",

author = "M. Jasek and Gondek, {L. P.} and N. Bejanyan and R. Tiu and J. Huh and Theil, {K. S.} and C. O'Keefe and McDevitt, {M. A.} and MacIejewski, {J. P.}",

note = "Funding Information: This work was supported in part by RO1HL-082983, U54 RR019391 K24 HL-077522 and by Grant from AA&MDS International Foundation and Robert Duggan Charitable Fund (JPM).",

year = "2010",

month = jan,

doi = "10.1038/leu.2009.189",

language = "English",

volume = "24",

pages = "216--219",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p. / Jasek, M.; Gondek, L. P.; Bejanyan, N.; Tiu, R.; Huh, J.; Theil, K. S.; O'Keefe, C.; McDevitt, M. A.; MacIejewski, J. P.

In: Leukemia, Vol. 24, No. 1, 01.2010, p. 216-219.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p

AU - Jasek, M.

AU - Gondek, L. P.

AU - Bejanyan, N.

AU - Tiu, R.

AU - Huh, J.

AU - Theil, K. S.

AU - O'Keefe, C.

AU - McDevitt, M. A.

AU - MacIejewski, J. P.

N1 - Funding Information: This work was supported in part by RO1HL-082983, U54 RR019391 K24 HL-077522 and by Grant from AA&MDS International Foundation and Robert Duggan Charitable Fund (JPM).

PY - 2010/1

Y1 - 2010/1

UR - http://www.scopus.com/inward/record.url?scp=74249120916&partnerID=8YFLogxK

U2 - 10.1038/leu.2009.189

DO - 10.1038/leu.2009.189

M3 - Letter

C2 - 19759556

AN - SCOPUS:74249120916

VL - 24

SP - 216

EP - 219

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 1

ER -